Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VIMPAT ®safely and effectively. See full prescribing information for VIMPAT. VIMPAT ®(lacosamide) film coated tablet, for oral use, CV VIMPAT ®(lacosamide) injection, for intravenous use, CV VIMPAT ®(lacosamide) oral solution, CV Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
VIMPAT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. VIMPAT is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.
- generic_name
- lacosamide
- product_names
- lacosamide
- ndc
- 0131-2477, 0131-2477-35, 0131-2477-60, 0131-2477-99, 0131-2478, 0131-2478-35, 0131-2478-60, 0131-2478-99, 0131-2479, 0131-2479-35, 0131-2479-60, 0131-2479-99, 0131-2480, 0131-2480-35, 0131-2480-60, 0131-2480-99, 0131-1810, 0131-1810-67, 0131-5410, 0131-5410-70, 0131-5410-71, 0131-5410-72
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en